首页|麻杏石甘汤加减对慢性阻塞性肺疾病急性加重期患者的影响

麻杏石甘汤加减对慢性阻塞性肺疾病急性加重期患者的影响

扫码查看
目的:分析麻杏石甘汤加减对慢性阻塞性肺疾病急性加重期(acute exacerbation of chronic obstructive pulmonary disease,AECOPD)患者的影响.方法:选取 2021 年 1 月—2023 年 6 月安溪县中医院呼吸与危重症医学科收治的 100 例AECOPD患者作为研究对象,按照随机数表法将患者分为对照组与研究组,各 50 例.对照组实施常规西医治疗,研究组在对照组基础上实施麻杏石甘汤加减治疗,两组均治疗 14 d.比较两组肺功能指标、动脉血气指标、血清炎症指标、中医症候评分、治疗效果.结果:治疗 14 d后,两组第 1 秒用力呼气容积(forced expiratory volume in one second,FEV1)、最大呼气流量(peak expiratory flow,PEF)、FEV1/用力肺活量(forced vital capacity,FVC)高于治疗前,且研究组高于对照组,差异有统计学意义(P<0.05).治疗 14 d后,两组(partial pressure of oxygen,PaO2)、血氧饱和度(arterial oxyhemoglobin saturation,SaO2)高于治疗前,二氧化碳分压(partial pressure of carbon dioxide,PaCO2)低于治疗前,且研究组治疗 14 d后PaCO2 低于对照组,差异有统计学意义(P<0.05);但两组治疗 14 d后PaO2、SaO2 比较,差异无统计学意义(P>0.05).治疗 14 d后,两组C反应蛋白(C-reactive protein,CRP)、降钙素原(procalcitonin,PCT)及中医症候评分低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05).研究组治疗总有效率高于对照组,差异有统计学意义(P<0.05).结论:麻杏石甘汤加减有利于改善AECOPD患者呼吸功能和治疗效果,减轻炎症反应,缓解临床症状.
Effect of Modified Maxing Shigan Decoction on Acute Exacerbation of Chronic Obstructive Pulmonary Disease Patients
Objective:To analyze the effect of modified Maxing Shigan Decoction on acute exacerbation of chronic obstructive pulmonary disease(AECOPD)patients.Method:A total of 100 patients with AECOPD who admitted to the Department of Respiratory and Critical Care Medicine of Anxi Hospital of Traditional Chinese Medicine from January 2021 to June 2023 were selected as the research objects,the patients were divided into the control group and the study group according to the random number table method,with 50 cases in each group.The control group was given routine western medicine treatment,the study group was treated with modified Maxing Shigan Decoction on the basis of the control group,and two groups were treated for 14 d.The pulmonary function indexes,arterial blood gas indexes,serum inflammatory indexes,traditional Chinese medicine symptom score and treatment effect were compared between two groups.Result:After 14 d of treatment,the forced expiratory volume in one second(FEV1),peak expiratory flow(PEF),FEV1/forced vital capacity(FVC)in two groups were higher than those before treatment,and those in the study group were higher than the control group,the differences were statistically significant(P<0.05).After 14 d of treatment,the partial pressure of oxygen(PaO2)and arterial oxyhemoglobin saturation(SaO2)in two groups were higher than those before treatment,and the partial pressure of carbon dioxide(PaCO2)were lower than those before treatment,PaCO2 in the study group after 14 d of treatment was lower than that in the control group,and the differences were statistically significant(P<0.05).There were no significant differences in PaO2 and SaO2 between the two groups after 14 d of treatment(P>0.05).After 14 d of treatment,the C-reactive protein(CRP),procalcitonin(PCT)and traditional Chinese medicine symptoms scores in two groups were lower than those before treatment,and those in the study group were lower than the control group,the differences were statistically significant(P<0.05).The total effective rate of treatment in the study group was higher than that in the control group,the difference was statistically significant(P<0.05).Conclusion:Modified Maxing Shigan Decoction is beneficial to improve the respiratory function and therapeutic effect of AECOPD patients,reduce the inflammatory response and relieve the clinical symptoms.

Modified Maxing Shigan DecoctionAcute exacerbation of chronic obstructive pulmonary diseaseRespiratory functionInflammatory markersEffect

叶翔扬、陈靖楠、上官坤常

展开 >

安溪县中医院 福建 安溪 362400

麻杏石甘汤加减 慢性阻塞性肺疾病急性加重期 呼吸功能 炎症指标 影响

2024

中外医学研究
中国医院管理杂志社

中外医学研究

影响因子:1.149
ISSN:1674-6805
年,卷(期):2024.22(34)